Is the frequency of screening for hepatitis B infection after educational intervention improving?: Comparison with left ventricular function testing

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Hepatitis B virus (HBV) reactivation is a complication of chemotherapy. But the frequency of testing for HBV before chemotherapy was low. An educational intervention was delivered to the oncology team. Of 98 new patients who received chemotherapy, 24.5% underwent HBsAb or anti-HBcAb screening before chemotherapy. But 89.2% of 65 patients who received cardiotoxic chemotherapy underwent LVF test After educational intervention, the frequency of HBV testing increased to 76.8% of 155 patients received chemotharapy, but still fell short of LVF testing. An intervention resulted a modest improvement To increase the frequency of HBV screening before chemotharapy, we feel that additional education of HBV reativation in solid tumor. © 2013 The Japan Society of Hepatology.

Cite

CITATION STYLE

APA

Kirishima, T., Kawamoto, Y., Okamoto, N., Takai, K., Motoyoshi, T., Nishikata, M., … Ito, Y. (2013). Is the frequency of screening for hepatitis B infection after educational intervention improving?: Comparison with left ventricular function testing. Kanzo/Acta Hepatologica Japonica, 54(8), 559–562. https://doi.org/10.2957/kanzo.54.559

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free